Connect with us

Hi, what are you looking for?

News

US Buys $290 Million Worth of Drugs in Preparation for Nuclear Emergencies

The U.S. Department of Health and Human Services (HHS) is buying $290 million worth of drugs as part of its “long-standing, ongoing efforts to be better prepared to save lives following radiological and nuclear emergencies.”

HHS is purchasing a supply of the drug Nplate from Amgen USA, a biotechnology headquartered in Thousand Oaks, California.

The $290 million purchase was announced on Oct. 4 by the Administration for Strategic Preparedness and Response (ASPR), an agency within the HHS that’s tasked with preparing the nation for future disasters and public health emergencies.

Nplate is the trade name of romiplostim, which was approved by the U.S. Food and Drug Administration (FDA) in January 2021 to treat blood cell injuries that accompany acute radiation syndrome (ARS) in adults and children.

ARS is also referred to as radiation sickness, which reaches internal organs in mere seconds and “occurs when a person’s entire body is exposed to a high dose of penetrating radiation.” It can result in a difficulty for blood to clot because of low platelet counts, which can lead to uncontrolled bleeding, which is life-threatening.

Nplate helps reduce the radiation-induced bleeding by stimulating the body to produce more platelets.

According to the announcement, Amgen’s development of Nplate for radiation sickness was supported by the Biomedical Advanced Research and Development Authority (BARDA) and the National Institute of Allergy and Infectious Diseases (NIAID). BARDA is part of the HHS ASPR, and NIAID is part of the National Institutes of Health (NIH).

“BARDA is using its authority provided under the 2004 Project Bioshield Act and $290 million in Project BioShield designated funding to purchase this supply of the drug,” the ASPR announcement reads.

The U.S. government launched Project Bioshield in 2004 to incentivize private companies to develop vaccines and other countermeasures to deal with future chemical, biological, radiological, and nuclear threats. It was initially provided with some $5.6 billion to be funded through fiscal year 2013, and later another $2.8 billion to be funded from FY 2014 to FY 2018.

“Amgen will maintain this supply in vendor-managed inventory,” ASPR said of the Nplate drug supply. “This approach decreases life-cycle management costs for taxpayers because doses that near expiration can be rotated into the commercial market for rapid use prior to expiry and new doses can be added to the government supply.”

NIAID announced in February 2021 that the FDA approval of romiplostim or Nplate was a result of its collaboration with BARDA and Amgen.

“The FDA’s decision was based largely on NIAID-supported studies showing that romiplostim greatly increases survival in an animal model of radiation exposure,” NIAID stated at the time.

Nplate is also otherwise FDA-approved for people with immune thrombocytopenia, a blood disorder that results in low platelet counts.

“Repurposing drugs for acute radiation syndrome that also are approved for a commercial indication helps to sustain availability of the product and improves healthcare provider familiarity with the drug,” ASPR announced on Oct. 4.

15 Comments
  • RJ Stone says:

    Sounds like a joke. These pills cost a minimum of $1,000 per dose, which equates to only 290,000 pills. Who are going to get these pills, dose one dose work or are the politicians the only ones to get them?

  • BarbMaga says:

    There’s so many getting a financial piece of this bs I don’t even know where to begin.

  • Richard Mundy says:

    I see the skeptical folks below are at work with the usual BS. This Administration is in a cat-and-mouse game with Russia it is very possible that Putin nukes Ukraine and America get involved there will be hell to pay for this we will need Iodine ” Nplate” treatment for sure. These Biden democratic’s are looking to get us into world war three. Just remember NATO will be in this and the EU as well this is no laughing matter we must be prepared for this possible outcome.

  • Trending Today

    News

    A bombshell Newsweek report details what most of us knew all along — that the FBI is increasingly spending its time and resources fighting...

    News

    Atlanta Hawks announcer Bob Rathbun suffered a scary medical emergency while on-air. Prior to Monday night’s game against the Thunder, while color commentator Dominique...

    News

    Joe Biden’s Assistant Secretary of Health’s leading mission from day one has been pushing the normalization of transgenderism in our nation’s children. This time,...

    News

    A top FBI official has stepped down just as House Republicans have announced plans to investigate recent operations and actions at the bureau. In...

    >